Allt inom Yearend
Nanexa publishes year-end report for 2022
Agreement and directed issue to Novo Nordisk, solution to patent infringement lawsuit and phase 1 study with NEX-20 started
Nanexa publishes year-end report for 2021
Additional evaluation agreement and positive results in preclinical investigation of NEX-18